Diligence memo · auto-generated · as of July 3, 2026
Wildflower Health, Inc.
Wildflower Health, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Wildflower Health, Inc. operates in Healthtech, based in SAN FRANCISCO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Wildflower Health, Inc. has raised $20M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $18M on 2024-11-27.
Most recent recorded round closed around 2024-11-27.
Valuation (modeled)modeled
Provath models Wildflower Health, Inc. at approximately $107M (range $42M–$177M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.65× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 132 months.
Last raise 19 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 10.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 80% of Healthtech peers (2138 compared).
Modeled value ranks above 77% of those peers.
Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.